Do peripartum and postmenopausal women with primary liver cancer have a worse prognosis? A nationwide cohort in Taiwan

Table 4 Demographic characteristics and comorbidities of female patients newly diagnosed with and without menopause primary liver cancer patients in Taiwan during 1996-2012

Characteristics	Total, N = 13440	Liver cancer		P value
		≥ 50 yr, n = 10752	< 50 yr, n = 2688
		n (%)/mean ± SD	n (%)/mean ± SD
Age
mean ± SD1		69.1 ± 9.6	39.7 ± 10.5	< 0.001
Baseline comorbidity
HBV	2971	2358 (21.9)	613 (22.8)	0.329
HCV	1168	931 (8.7)	237 (8.8)	0.795
Unspecified chronic hepatitis	780	619 (5.8)	161 (6)	0.645
Alcoholic liver disease	211	157 (1.5)	54 (2)	0.041
Cirrhosis	4142	3321 (30.9)	821 (30.5)	0.730
Biliary stone	1269	1012 (9.4)	257 (9.6)	0.813
Cholecystitis	626	489 (4.5)	137 (5.1)	0.227
Cholangitis	818	649 (6)	169 (6.3)	0.626

¹t-test, Chi-square test.

HBV: Hepatitis B virus; HCV: Hepatitis C virus; SD: Standard deviation.